Our sister company, APL, recently announced 24 promising focus items. These items are promising items whose global market is expected to expand by more than 15% annually within the next 10 years. APL plans to find CMO operators or investors, build a production system within three years, and expand the global market in cooperation with HERUN TRADE. APL and HERUN TRADE have a vision to achieve $25 billion within 5 years and $50 billion within 7 years.
- previous:Beta Nicotinamide mononucleotide
- next:nothing
reading
- Key items[2021-10-27]
- Beta Nicotinamide mononucleotide[2021-10-28]
- Participate in Pharmaconex Egypt 2018[2018-05-15]
- Activity in API Xiamen China[2017-11-23]
- Activity in CPHI Frankfurt[2017-11-03]